Patent Yard Sign in
Expired European patentEurope

Cross-linked gelatin gel preparation containing basic fibroblast growth factor

EP 0702959 B1 · Applicant: KAKEN PHARMACEUTICAL CO., LTD.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed May 31, 1994 and granted August 8, 2001. A European patent lasts at most 20 years from filing, so its term ended May 31, 2014.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by December 1, 2019.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMay 31, 1994
PublishedMarch 27, 1996
GrantedAugust 8, 2001
Term endedMay 31, 2014
Application numberEP 94916430
Classification (CPC)A61K9/2063 +2 more

Timeline

Timeline From EPO dates

1995199719992001200320052007200920112013Application filedMay 31, 1994PublishedMarch 27, 1996Patent grantedAug 8, 2001Term endedMay 31, 2014

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.